Vir Biotechnology (NASDAQ:VIR – Get Free Report) had its target price lowered by Barclays from $59.00 to $41.00 in a research note issued to investors on Friday, FlyOnTheWall reports. Barclays‘s price objective suggests a potential upside of 222.83% from the stock’s current price. Other analysts have also recently issued reports about the company. Needham & […]
Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) Director Vicki L. Sato sold 1,666 shares of the stock in a transaction dated Monday, July 17th. The shares were sold at an average price of $29.60, for a total transaction of $49,313.60. Following the completion of the transaction, the director now directly owns 133,037 shares of […]
Analysts Set Vir Biotechnology, Inc (NASDAQ:VIR) Target Price at $49 75 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) – Equities researchers at Cantor Fitzgerald issued their FY2024 EPS estimates for Denali Therapeutics in a report issued on Tuesday, July 11th. Cantor Fitzgerald analyst C. Duncan anticipates that the company will post earnings per share of ($4.51) for the year. The consensus estimate for Denali Therapeutics’ current […]
Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) – Cantor Fitzgerald issued their FY2024 EPS estimates for shares of Denali Therapeutics in a research report issued to clients and investors on Tuesday, July 11th. Cantor Fitzgerald analyst C. Duncan anticipates that the company will post earnings per share of ($4.51) for the year. The consensus estimate […]